KELLI BRIDGMAN: Open Payments
NPI 1588841977 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,405 in 173 payments from 15 companies in 2025. Trend: 2023 $15,384 · 2024 $13,905 · 2025 $30,405
Honoraria: $14,500Speaker / faculty: $5,500Travel & lodging: $4,502Food & beverage: $3,863Consulting: $2,040
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 43 | $19,041 |
| ABBVIE INC. | 33 | $5,969 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 41 | $4,176 |
| E.R. Squibb & Sons, L.L.C. | 11 | $237 |
| Vanda Pharmaceuticals Inc. | 9 | $198 |
| Alkermes, Inc. | 6 | $179 |
| Otsuka America Pharmaceutical, Inc. | 8 | $169 |
| Neurocrine BioSciences, Inc. | 8 | $156 |
| Almatica Pharma LLC | 3 | $73 |
| Corium, LLC | 3 | $53 |
Products named: Auvelity, VRAYLAR, CAPLYTA, COBENFY, ARISTADA, FANAPT, REXULTI, INGREZZA.
Industry payments across FL — which companies pay providers there.
